Natural killer cells in antitumour adoptive cell immunotherapy

TJ Laskowski, A Biederstädt, K Rezvani - Nature Reviews Cancer, 2022 - nature.com
Natural killer (NK) cells comprise a unique population of innate lymphoid cells endowed with
intrinsic abilities to identify and eliminate virally infected cells and tumour cells. Possessing …

Signalling mechanisms and cellular functions of SUMO

ACO Vertegaal - Nature Reviews Molecular Cell Biology, 2022 - nature.com
Sumoylation is an essential post-translational modification that is catalysed by a small
number of modifying enzymes but regulates thousands of target proteins in a dynamic …

Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications

Q Zhong, X **ao, Y Qiu, Z Xu, C Chen, B Chong… - MedComm, 2023 - Wiley Online Library
Protein posttranslational modifications (PTMs) refer to the breaking or generation of covalent
bonds on the backbones or amino acid side chains of proteins and expand the diversity of …

Discovery of TAK-981, a first-in-class inhibitor of SUMO-activating enzyme for the treatment of cancer

SP Langston, S Grossman, D England… - Journal of medicinal …, 2021 - ACS Publications
SUMOylation is a reversible post-translational modification that regulates protein function
through covalent attachment of small ubiquitin-like modifier (SUMO) proteins. The process of …

Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model

S Kumar, MJA Schoonderwoerd, JS Kroonen… - Gut, 2022 - gut.bmj.com
Objective Pancreatic ductal adenocarcinoma (PDAC) has the characteristics of high-density
desmoplastic stroma, a distinctive immunosuppressive microenvironment and is profoundly …

Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer

UM Demel, M Böger, S Yousefian, C Grunert… - The Journal of Clinical …, 2022 - jci.org
Activated SUMOylation is a hallmark of cancer. Starting from a targeted screening for SUMO-
regulated immune evasion mechanisms, we identified an evolutionarily conserved function …

Targeting SUMO signaling to wrestle cancer

JS Kroonen, ACO Vertegaal - Trends in cancer, 2021 - cell.com
The small ubiquitin-like modifier (SUMO) signaling cascade is critical for gene expression,
genome integrity, and cell cycle progression. In this review, we discuss the important role …

Modeling pancreatic cancer in mice for experimental therapeutics

K Mallya, SK Gautam, A Aithal, SK Batra… - Biochimica et Biophysica …, 2021 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy that is
characterized by early metastasis, low resectability, high recurrence, and therapy resistance …

The emerging roles of SUMOylation in the tumor microenvironment and therapeutic implications

Y Gu, Y Fang, X Wu, T Xu, T Hu, Y Xu, P Ma… - … Hematology & Oncology, 2023 - Springer
Tumor initiation, progression, and response to therapies depend to a great extent on
interactions between malignant cells and the tumor microenvironment (TME), which denotes …

[HTML][HTML] Therapeutic potential of targeting the SUMO pathway in cancer

A Kukkula, VK Ojala, LM Mendez, L Sistonen… - Cancers, 2021 - mdpi.com
Simple Summary The small ubiquitin-like modifier (SUMO) pathway regulates the hallmark
properties of cancer cells. Moreover, alterations in activity and in levels of SUMO machinery …